Analyst Price Targets — MLAB
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 4, 2026 11:32 am | — | Wells Fargo | $94.00 | $87.53 | TheFly | Mesa Labs price target raised to $94 from $83 at Wells Fargo |
| December 15, 2025 11:28 am | — | Wells Fargo | $83.00 | $77.76 | TheFly | Mesa Labs price target raised to $83 from $75 at Wells Fargo |
| August 27, 2024 4:19 pm | Brandon Couillard | Wells Fargo | $120.00 | $140.86 | TheFly | Mesa Labs initiated with an Underweight at Wells Fargo |
| June 7, 2024 8:15 am | Vijay Kumar | Evercore ISI | $120.00 | $104.80 | StreetInsider | Evercore ISI Removes Mesa Laboratories (MLAB) from TAP List |
Latest News for MLAB
Principal Financial Group Inc. lessened its stake in Mesa Laboratories, Inc. (NASDAQ: MLAB) by 66.2% in the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 10,065 shares of the medical instruments supplier's stock after selling 19,713 shares during the quarter. Principal Financial Group
Diamond Hill Capital Management Inc. grew its holdings in shares of Mesa Laboratories, Inc. (NASDAQ: MLAB) by 218.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 123,381 shares of the medical instruments supplier's stock after purchasing an additional 84,582
Mesa Laboratories (NASDAQ: MLAB - Get Free Report) is projected to issue its Q3 2026 results before the market opens on Tuesday, February 3rd. Analysts expect the company to announce earnings of $2.41 per share and revenue of $63.2330 million for the quarter. Individuals may visit the the company's upcoming Q3 2026 earning results page for
Mesa Laboratories, Inc. (MLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
LAKEWOOD, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 16, 2026, to shareholders of record at the close of business on February 28, 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MLAB.
U.S. House Trading
No House trades found for MLAB.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.